Healthcare provider profile · identity verified

John William Kerns, MD

Family Practice · FRONT ROYAL, VA · NPI 1366410664

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	304	78
Rosuvastatin Calcium	Rosuvastatin Calcium	211	51
Lisinopril	Lisinopril	167	50
Amlodipine Besylate	Amlodipine Besylate	117	35
Metoprolol Succinate	Metoprolol Succinate	111	35
Irbesartan	Irbesartan	110	27
Levothyroxine Sodium	Levothyroxine Sodium	108	29
Eliquis	Apixaban	97	21
Alfuzosin Hcl Er	Alfuzosin Hcl	94	19
Omeprazole	Omeprazole	93	31
Clopidogrel	Clopidogrel Bisulfate	92	19
Famotidine	Famotidine	92	26
Pantoprazole Sodium	Pantoprazole Sodium	85	24
Furosemide	Furosemide	77	21
Gabapentin	Gabapentin	77	16
Ezetimibe	Ezetimibe	74	20
Tamsulosin Hcl	Tamsulosin Hcl	72	19
Albuterol Sulfate Hfa	Albuterol Sulfate	69	18
Losartan Potassium	Losartan Potassium	63	19
Hydrochlorothiazide	Hydrochlorothiazide	60	20
Metformin Hcl Er	Metformin Hcl	59	18
Metformin Hcl	Metformin Hcl	56	16
Potassium Chloride	Potassium Chloride	56	18
Fluticasone Propionate	Fluticasone Propionate	52	17
Jardiance	Empagliflozin	49	16
Montelukast Sodium	Montelukast Sodium	49	17
Allopurinol	Allopurinol	47	11
Spironolactone	Spironolactone	45	11
Bumetanide	Bumetanide	41	11
Bupropion Xl	Bupropion Hcl	41	11
Chlorthalidone	Chlorthalidone	39	11
Prednisone	Prednisone	39	29
Escitalopram Oxalate	Escitalopram Oxalate	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Trulicity	Dulaglutide	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Sertraline Hcl	Sertraline Hcl	35	suppressed
Finasteride	Finasteride	34	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	33	12
Mirtazapine	Mirtazapine	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Meloxicam	Meloxicam	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	28	suppressed
Armour Thyroid	Thyroid,pork	24	suppressed
Atenolol	Atenolol	23	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Simvastatin	Simvastatin	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Azithromycin	Azithromycin	19	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Clonazepam	Clonazepam	16	suppressed
Trazodone Hcl	Trazodone Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Cephalexin	Cephalexin	14	11
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Carvedilol	Carvedilol	12	suppressed
Diazepam	Diazepam	12	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Cefdinir	Cefdinir	11	11
Fluconazole	Fluconazole	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error